Literature DB >> 8796258

Tuberculosis case finding in remote mountainous areas--are microscopy camps of any value? Experience from Nepal.

I Harper1, R Fryatt, A White.   

Abstract

SETTING: In the remote hills of North-East Nepal tuberculosis case-finding is believed to be low. The Britain-Nepal Medical Trust (BNMT), a well funded non-governmental organisation supporting Tuberculosis Control Programmes in this area, has a stable structure and sufficiently high case-holding to explore ways to increase case-finding.
OBJECTIVES: To increase case-finding without decreasing case-holding, by expanding outreach services into remote areas away from existing health services.
DESIGN: Between 1990 and 1993, 45 temporary outreach tuberculosis diagnostic "microscopy camps' were run in the eight districts covered by the BNMT (population 1330000). Camp-diagnosed patients were followed up by cohort.
RESULTS: The camps did not appreciably increase the low rate of case-finding. However, the percentage of women who attended the camps was significantly higher than at existing services, as was the number diagnosed with smear-positive tuberculosis. The cured treatment completion rate of this camp-diagnosed cohort was 76%. Cost analysis revealed a low overall additional cost to the programme; however, it would be prohibitively expensive for an under-funded government health service.
CONCLUSIONS: The implications of these camps go beyond tuberculosis control in their ability to reach those who would otherwise not utilise health care facilities.

Entities:  

Mesh:

Year:  1996        PMID: 8796258     DOI: 10.1016/s0962-8479(96)90107-0

Source DB:  PubMed          Journal:  Tuber Lung Dis        ISSN: 0962-8479


  8 in total

Review 1.  Active case finding of tuberculosis: historical perspective and future prospects.

Authors:  J E Golub; C I Mohan; G W Comstock; R E Chaisson
Journal:  Int J Tuberc Lung Dis       Date:  2005-11       Impact factor: 2.373

2.  Tuberculosis and indoor biomass and kerosene use in Nepal: a case-control study.

Authors:  Amod K Pokhrel; Michael N Bates; Sharat C Verma; Hari S Joshi; Chandrashekhar T Sreeramareddy; Kirk R Smith
Journal:  Environ Health Perspect       Date:  2010-04       Impact factor: 9.031

3.  Active case-finding policy development, implementation and scale-up in high-burden countries: A mixed-methods survey with National Tuberculosis Programme managers and document review.

Authors:  Olivia Biermann; Phuong Bich Tran; Kerri Viney; Maxine Caws; Knut Lönnroth; Kristi Sidney Annerstedt
Journal:  PLoS One       Date:  2020-10-28       Impact factor: 3.240

4.  Feasibility, yield, and cost of active tuberculosis case finding linked to a mobile HIV service in Cape Town, South Africa: a cross-sectional study.

Authors:  Katharina Kranzer; Stephen D Lawn; Gesine Meyer-Rath; Anna Vassall; Eudoxia Raditlhalo; Darshini Govindasamy; Nienke van Schaik; Robin Wood; Linda-Gail Bekker
Journal:  PLoS Med       Date:  2012-08-07       Impact factor: 11.069

Review 5.  Screening strategies for active tuberculosis: focus on cost-effectiveness.

Authors:  Claudia Caroline Dobler
Journal:  Clinicoecon Outcomes Res       Date:  2016-06-30

6.  Building on facilitators and overcoming barriers to implement active tuberculosis case-finding in Nepal, experiences of community health workers and people with tuberculosis.

Authors:  Olivia Biermann; Kritika Dixit; Bhola Rai; Maxine Caws; Knut Lönnroth; Kerri Viney
Journal:  BMC Health Serv Res       Date:  2021-04-01       Impact factor: 2.655

7.  Factors influencing active tuberculosis case-finding policy development and implementation: a scoping review.

Authors:  Olivia Biermann; Knut Lönnroth; Maxine Caws; Kerri Viney
Journal:  BMJ Open       Date:  2019-12-11       Impact factor: 2.692

8.  Does tuberculosis screening improve individual outcomes? A systematic review.

Authors:  L Telisinghe; M Ruperez; M Amofa-Sekyi; L Mwenge; T Mainga; R Kumar; M Hassan; L H Chaisson; F Naufal; A E Shapiro; J E Golub; C Miller; E L Corbett; R M Burke; P MacPherson; R J Hayes; V Bond; C Daneshvar; E Klinkenberg; H M Ayles
Journal:  EClinicalMedicine       Date:  2021-09-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.